Nils-Erik Anden

Title: Nils-Erik Anden: Innovator in Pharmaceutical Chemistry

Introduction

Nils-Erik Anden is a notable inventor based in Sp.ang.nga, Sweden. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on compounds that target the central nervous system.

Latest Patents

Nils-Erik Anden holds a patent for a compound known as 8-substituted-2-aminotetralins. This compound is characterized by a complex formula where Z can be hydrogen or halogen, and Q can be COR¹ or a 5- or 6-membered aryl. The patent also details various configurations and substitutions for R, R¹, R², and R³, along with processes for preparing these compounds. The applications of this invention include pharmaceutical preparations and methods for treating disorders in the central nervous system.

Career Highlights

Nils-Erik Anden is associated with Astra Aktiebolag, a prominent company in the pharmaceutical industry. His work at Astra has allowed him to focus on developing innovative solutions for medical challenges, particularly in the realm of CNS disorders.

Collaborations

Throughout his career, Nils-Erik has collaborated with esteemed colleagues such as Anna L Bjork and Berit C Backlund Hook. These collaborations have contributed to the advancement of research and development in their field.

Conclusion

Nils-Erik Anden's contributions to pharmaceutical chemistry, particularly through his patent on 8-substituted-2-aminotetralins, highlight his role as an innovator in the industry. His work continues to influence the development of treatments for central nervous system disorders.